US4301176A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of administering calcium valproate
Assignee: Warner Lambert Co LLC
•
Filing: 1980-08-18
•
Granted: 1981-11-17
•
Expires: 2000-08-18
Abstract
Abstract A chewable anticonvulsant tablet dosage form consisting essentially of calcium valproate and a pharmaceutically acceptable carrier is disclosed. This novel dosage form is conveniently administered and is not irritating to the mucosa of the mouth and throat.
Inventors
- 👤 Albert T. Grabowski
- 👤 Sadath U. Khan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:05
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0053; A61K9/0056; A61K31/00; A61K31/185; A61K31/19; A61K31/20
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
33 words
A method of treating a human being suffering from convulsions, which comprises administering to said human being, a chewable anticonvulsant tablet dosage form consisting essentially of calcium valproate and a pharmaceutically acceptable carrier.
Claim 2
Independent Claim
33 words
A method of treating a human being suffering from convulsions, which comprises administering to said human being, a chewable anticonvulsant tablet dosage form consisting essentially of calcium valproate and a pharmaceutically acceptable carrier.
Claim 3
Dependent Claim
26 words
The method as defined in claim 1 wherein said dosage form; consists essentially of calcium valproate, powdered sugar, mannitol, polyvinylpyrrolidone, calcium stearate and a flavoring agent.
Claim 4
Dependent Claim
28 words
The method as defined in claim 2 wherein the calcium valproate is present in said dosage form in an amount equivalent to about 125 mg of valproic acid.
Claim 5
Dependent Claim
28 words
The method as defined in claim 2 wherein the calcium valproate is present in said dosage form in an amount equivalent to about 250 mg of valproic acid.
Claim 6
Dependent Claim
19 words
The method as defined in claim 3 wherein the flavoring agent is oil of peppermint or oil of spearmint.
Claim 7
Dependent Claim
19 words
The method as defined in claim 4 wherein the flavoring agent is oil of peppermint or oil of spearmint.
Claim 8
Dependent Claim
16 words
A method as defined in claim 1, whereby irritation of the mouth and throat is avoided.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-11-16 | 1985-05-18 | 1985-11-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-11-16 | 1989-05-18 | 1989-11-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-11-16 | 1993-05-18 | 1993-11-17 | $7700.00 | Window Closed / Lapsed |